Total Payments
$155,219
2024 Payments
$359.66
Companies
15
Transactions
208
Medicare Patients
1,228
Medicare Billing
$259,134
Payment Breakdown by Category
Other$139,150 (89.6%)
Food & Beverage$6,422 (4.1%)
Travel$4,898 (3.2%)
Consulting$4,750 (3.1%)
Payments by Nature
| Nature of Payment | Amount | Transactions | Share |
|---|---|---|---|
| Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | $139,150 | 52 | 89.6% |
| Food and Beverage | $6,422 | 93 | 4.1% |
| Travel and Lodging | $4,898 | 62 | 3.2% |
| Consulting Fee | $4,750 | 1 | 3.1% |
Top Paying Companies
| Company | Total | Records | Latest Year |
|---|---|---|---|
| Alkermes, Inc. | $154,830 | 187 | $0 (2023) |
| IRONSHORE PHARMACEUTICALS INC. | $82.92 | 4 | $0 (2024) |
| Corium, LLC | $47.79 | 2 | $0 (2024) |
| Tris Pharma Inc | $35.13 | 2 | $0 (2024) |
| ABBVIE INC. | $29.59 | 2 | $0 (2024) |
| Lundbeck LLC | $28.91 | 2 | $0 (2024) |
| E.R. Squibb & Sons, L.L.C. | $23.82 | 1 | $0 (2024) |
| Almatica Pharma LLC | $23.42 | 1 | $0 (2024) |
| Bausch Health US, LLC | $22.91 | 1 | $0 (2024) |
| Otsuka America Pharmaceutical, Inc. | $19.43 | 1 | $0 (2024) |
Payment History by Year
| Year | Amount | Transactions | Top Company |
|---|---|---|---|
| 2024 | $359.66 | 19 | IRONSHORE PHARMACEUTICALS INC. ($82.92) |
| 2023 | $20,462 | 25 | Alkermes, Inc. ($20,462) |
| 2022 | $40,286 | 56 | Alkermes, Inc. ($40,286) |
| 2021 | $35,342 | 38 | Alkermes, Inc. ($35,342) |
| 2020 | $14,231 | 16 | Alkermes, Inc. ($14,231) |
| 2019 | $44,498 | 52 | Alkermes, Inc. ($44,487) |
| 2018 | $23.51 | 1 | Alkermes, Inc. ($23.51) |
| 2017 | $17.51 | 1 | Sunovion Pharmaceuticals Inc. ($17.51) |
All Payment Transactions
208 individual payment records from CMS Open Payments — Page 1 of 9
| Date | Company | Product | Nature | Form | Amount | Type |
|---|---|---|---|---|---|---|
| 12/19/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $22.49 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/16/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $15.29 | General |
| Category: PSYCHIATRY | ||||||
| 12/10/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.76 | General |
| Category: NEUROSCIENCE | ||||||
| 12/05/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.98 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 12/04/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $15.24 | General |
| Category: ADHD | ||||||
| 12/03/2024 | Otsuka America Pharmaceutical, Inc. | ABILIFY ASIMTUFII (Drug), ABILIFY MAINTENA | Food and Beverage | In-kind items and services | $19.43 | General |
| Category: PSYCHIATRY | ||||||
| 12/03/2024 | Supernus Pharmaceuticals, Inc. | Qelbree (Drug) | Food and Beverage | In-kind items and services | $16.56 | General |
| Category: VILOXAZINE HYDROCHLORIDE | ||||||
| 11/26/2024 | ABBVIE INC. | VRAYLAR (Drug) | Food and Beverage | In-kind items and services | $14.83 | General |
| Category: NEUROSCIENCE | ||||||
| 11/20/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $17.35 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 11/19/2024 | Neurocrine Biosciences, Inc. | INGREZZA (Drug) | Food and Beverage | In-kind items and services | $13.99 | General |
| Category: Neuropsychiatry | ||||||
| 11/13/2024 | Takeda Pharmaceuticals U.S.A., Inc. | TRINTELLIX (Drug) | Food and Beverage | In-kind items and services | $15.19 | General |
| Category: NEUROSCIENCE | ||||||
| 11/06/2024 | Bausch Health US, LLC | APLENZIN (Drug), WELLBUTRIN | Food and Beverage | In-kind items and services | $22.91 | General |
| Category: Neurology | ||||||
| 10/25/2024 | E.R. Squibb & Sons, L.L.C. | COBENFY (Drug) | Food and Beverage | Cash or cash equivalent | $23.82 | General |
| Category: Psychiatry/Psychology | ||||||
| 10/15/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $20.30 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 10/08/2024 | Almatica Pharma LLC | LOREEV XR (Drug) | Food and Beverage | In-kind items and services | $23.42 | General |
| Category: ANTI-ANXIETY | ||||||
| 09/26/2024 | Corium, LLC | Azstarys (Drug) | Food and Beverage | In-kind items and services | $27.49 | General |
| Category: CNS Stimulant for ADHD | ||||||
| 08/27/2024 | Lundbeck LLC | REXULTI (Drug) | Food and Beverage | Cash or cash equivalent | $13.62 | General |
| Category: PSYCHIATRY | ||||||
| 08/21/2024 | Tris Pharma Inc | Dyanavel XR (Drug) | Food and Beverage | In-kind items and services | $19.89 | General |
| Category: ADHD | ||||||
| 07/16/2024 | IRONSHORE PHARMACEUTICALS INC. | JORNAY PM (Drug) | Food and Beverage | Cash or cash equivalent | $21.10 | General |
| Category: CENTRAL NERVOUS SYSTEM STIMULANT | ||||||
| 07/25/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: CNS | ||||||
| 07/06/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program | Cash or cash equivalent | $2,750.00 | General |
| Category: CNS | ||||||
| 06/30/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Travel and Lodging | In-kind items and services | $84.00 | General |
| Category: CNS | ||||||
| 06/30/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Food and Beverage | In-kind items and services | $41.14 | General |
| Category: CNS | ||||||
| 06/30/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Travel and Lodging | In-kind items and services | $38.26 | General |
| Category: CNS | ||||||
| 06/30/2023 | Alkermes, Inc. | ARISTADA (Drug), ARISTADA, ARISTADA | Travel and Lodging | In-kind items and services | $30.00 | General |
| Category: CNS | ||||||
Medicare Billing by Year
| Year | Procedures | Beneficiaries | Services | Submitted | Medicare Paid |
|---|---|---|---|---|---|
| 2023 | 4 | 217 | 586 | $109,854 | $44,810 |
| 2022 | 4 | 231 | 697 | $127,809 | $51,025 |
| 2021 | 4 | 383 | 1,100 | $201,141 | $83,985 |
| 2020 | 6 | 397 | 950 | $180,636 | $79,313 |
Total Patients
1,228
Total Services
3,333
Medicare Billing
$259,134
Procedure Codes
18
All Medicare Procedures & Services
18 procedure records from CMS Medicare Utilization
| HCPCS | Description | Setting | Year | Patients | Services | Charges | Medicare Paid | Ratio |
|---|---|---|---|---|---|---|---|---|
| 99232 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 35 minutes | Facility | 2023 | 70 | 391 | $58,885 | $24,637 | 41.8% |
| 99233 | Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes | Facility | 2023 | 58 | 98 | $22,040 | $9,459 | 42.9% |
| 99223 | Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes | Facility | 2023 | 46 | 50 | $19,200 | $6,493 | 33.8% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2023 | 43 | 47 | $9,729 | $4,222 | 43.4% |
| 99232 | Follow-up hospital inpatient care per day, typically 25 minutes | Facility | 2022 | 76 | 396 | $57,420 | $22,830 | 39.8% |
| 99233 | Follow-up hospital inpatient care per day, typically 35 minutes | Facility | 2022 | 58 | 192 | $38,976 | $15,814 | 40.6% |
| 99223 | Initial hospital inpatient care per day, typically 70 minutes | Facility | 2022 | 46 | 50 | $19,200 | $7,395 | 38.5% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2022 | 51 | 59 | $12,213 | $4,986 | 40.8% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2021 | 109 | 631 | $89,923 | $37,493 | 41.7% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2021 | 103 | 270 | $53,946 | $22,741 | 42.2% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2021 | 84 | 97 | $36,558 | $14,845 | 40.6% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2021 | 87 | 102 | $20,714 | $8,905 | 43.0% |
| 99232 | Subsequent hospital inpatient care, typically 25 minutes per day | Facility | 2020 | 105 | 479 | $67,185 | $29,083 | 43.3% |
| 99233 | Subsequent hospital inpatient care, typically 35 minutes per day | Facility | 2020 | 95 | 253 | $49,838 | $21,955 | 44.1% |
| 99223 | Initial hospital inpatient care, typically 70 minutes per day | Facility | 2020 | 91 | 103 | $38,368 | $16,847 | 43.9% |
| 99239 | Hospital discharge day management, more than 30 minutes | Facility | 2020 | 81 | 90 | $18,113 | $8,029 | 44.3% |
| 99285 | Emergency department visit, problem with significant threat to life or function | Facility | 2020 | 13 | 13 | $4,096 | $1,981 | 48.4% |
| 99222 | Initial hospital inpatient care, typically 50 minutes per day | Facility | 2020 | 12 | 12 | $3,036 | $1,419 | 46.7% |
About Dr. Samuel Wedes, MD
Dr. Samuel Wedes, MD is a Psychiatry healthcare provider based in Livonia, Michigan. This provider has been registered with the National Plan and Provider Enumeration System (NPPES) since 08/29/2010. The National Provider Identifier (NPI) number assigned to this provider is 1194031062.
According to the Centers for Medicare & Medicaid Services (CMS) Open Payments database, Dr. Samuel Wedes, MD has received a total of $155,219 in payments from pharmaceutical and medical device companies, with $359.66 received in 2024. These payments were reported across 208 transactions from 15 companies. The most common payment nature is "Compensation for services other than consulting, including serving as faculty or as a speaker at a venue other than a continuing education program" ($139,150).
As a Medicare-enrolled provider, Wedes has provided services to 1,228 Medicare beneficiaries, totaling 3,333 services with total Medicare billing of $259,134. Data is available for 4 years (2020–2023), covering 18 distinct procedure/service records.
Ad
Practice Information
- Specialty Psychiatry
- Location Livonia, MI
- Active Since 08/29/2010
- Last Updated 06/03/2020
- Taxonomy Code 2084P0800X
- Entity Type Individual
- NPI Number 1194031062
Products in Payments
- ARISTADA (Drug) $129,230
- LYBALVI (Drug) $25,576
- JORNAY PM (Drug) $82.92
- Azstarys (Drug) $47.79
- Dyanavel XR (Drug) $35.13
- VRAYLAR (Drug) $29.59
- REXULTI (Drug) $28.91
- COBENFY (Drug) $23.82
- Aristada 441 mg (Drug) $23.51
- LOREEV XR (Drug) $23.42
- APLENZIN (Drug) $22.91
- ABILIFY ASIMTUFII (Drug) $19.43
- LATUDA (Drug) $17.51
- Qelbree (Drug) $16.56
- TRINTELLIX (Drug) $15.19
- INGREZZA (Drug) $13.99
- SPRAVATO (Drug) $11.74
Data Sources
Provider data from NPPES. Payment data from CMS Open Payments. Medicare data from CMS Medicare Provider Utilization. All data is public and updated periodically.
Psychiatry Doctors in Livonia
Bryan Weinstein, D.o, D.O
Psychiatry — Payments: $15,180
Psychiatry $15,180
Dr. Patrick Gresham, M.d, M.D
Psychiatry — Payments: $13,507
Psychiatry $13,507
Chalakudy Ramakrishna, Md Pc, MD PC
Psychiatry — Payments: $11,893
Psychiatry $11,893
Dr. Sridevi Kodali, M.d, M.D
Psychiatry — Payments: $8,548
Psychiatry $8,548
Dr. Srinivasa Kodali
Psychiatry — Payments: $6,876
Psychiatry $6,876
Debra Glitz, Md, MD
Psychiatry — Payments: $3,600
Psychiatry $3,600